Related Experiment Video

Updated: Apr 24, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
13:20

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro

Published on: July 17, 2018

9.9K

Equol induces mitochondria-mediated apoptosis of human cervical cancer cells

Eun Young Kim1, Jin Young Shin1, Young-Ja Park1

  • 1College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.

Anticancer Research
|September 10, 2014
PubMed
Abstract

Insights

Equol demonstrates anticancer effects against cervical cancer cells by inducing apoptosis and altering mitochondrial function. This natural compound shows promise as a therapeutic agent, warranting further investigation.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Cervical cancer remains a significant global health concern.
  • Investigating novel therapeutic agents is crucial for improving treatment outcomes.
  • Equol, a metabolite of isoflavones, possesses potential biological activities.

Purpose of the Study:

  • To explore the anticancer properties of equol in human cervical cancer (HeLa) cells.
  • To elucidate the molecular mechanisms underlying equol's cytotoxic effects.
  • To evaluate equol's impact on cell viability, apoptosis, and mitochondrial function.

Main Methods:

  • Cell viability assessed using MTT assay.
  • Apoptosis evaluated via morphological changes and Annexin-V staining.
  • Western blotting analyzed apoptosis-related proteins.
  • Mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) measured by flow cytometry.

Main Results:

  • Equol inhibited HeLa cell proliferation in a dose- and time-dependent manner.
  • Equol induced apoptosis, evidenced by caspase activation and altered mitochondrial proteins.
  • Equol triggered reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP) disruption.
  • N-acetylcysteine pre-treatment partially reversed equol-induced effects, highlighting ROS and mitochondrial pathways.

Conclusions:

  • Equol exhibits significant anticancer potential against human cervical cancer HeLa cells.
  • The mechanisms involve the generation of reactive oxygen species (ROS) and alterations in mitochondrial membrane potential.
  • Equol represents a promising candidate for further development as an anticancer agent.
Keywords:
Equolapoptosiscaspasecervical cancer cellsmitochondria

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.6K

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
914